Indian Court Rebuffs Bayer In Bolar Exemption Case

 
• By Anju Ghangurde
  
Bayer
THE DELHI HIGH COURT HAS SPECIFIED THE CONTOURS OF THE BOLAR PROVISION
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Business

More from Scrip